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SUMMARY – Th  e purpose of the current study was to evaluate the prevalence of female sexual 
dysfunction in Slovenia. We aimed to explore the prevalence itself, comparison among demographic 
groups and potential correlations. Data were collected based on the validated standardized Female 
Sexual Function Index (FSFI) (N=605). Most participants had sexual intercourse with one partner 
(n=523), and the majority of sexual relationships were heterosexual (n=584). University educated sub-
jects had the highest claims of arousal, followed by those with master/doctoral degrees and college edu-
cated ones. Th e lowest level was expressed by subjects with elementary school. Th e youngest subjects 
(18-23 years) expressed the highest levels of desire and arousal, followed by the 24-29 age group. Th e 
42-47 age group reported higher levels of lubrication and orgasm. Th e claim of satisfaction was highest 
in the 24-29 age group, while the pain was highest in the 42-47 age group. Strong correlation was found 
between the claims of desire and arousal (r=0.585), arousal and lubrication (r=0.879), lubrication and 
pain (r=0.856), orgasm and lubrication (r=0.856), satisfaction and orgasm (r=0.782), and pain and 
arousal (r=0.776) (p<0.001). We identifi ed a 31% prevalence of female sexual dysfunction in Slovenia.
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Introduction
In general, sexual dysfunction is defi ned as dyspa-
reunia1, as well as the absence of sexual desire, arousal, 
and stages of orgasm. Several studies have focused on 
diff erent factors of infl uence that, according to the au-
thors, could contribute to the incidence of female sexual 
dysfunction (FSD). Th e infl uencing factors might be 
physiological, psychological, negative experiences in re-
lationships, low levels of happiness and overall well-
being, emotional distress, sexual desire disorders, sexu-
al arousal disorder, orgasmic disorder, sexual pain dis-
orders, beliefs, past and present experiences/relation-
ships, lifestyle, and other mood disorders2-32. 
Investigations have also focused on linkages between 
changes in sexual arousal and menopause. Moreover, 
typical vaginal symptoms such as dryness discomfort 
are associated with decreased desire due to progressive 
chronologic aging2. FSD traditionally includes sexual 
desire disorders, sexual arousal disorders, orgasmic dis-
orders, and sexual pain disorders during and/or after 
sexual intercourse15,16,32. Authors have indicated that this 
problem remains uninvestigated33. A high prevalence of 
FSD predicts lower/poorer female sexual functioning34. It 
diff ers in various age groups and achieves high prevalence 
in more mature ages and relationships35,37.
Mo st epidemiological studies indicate the prevalence 
of FSD at 37%-40%38,39, e.g., 25%-63% in the American 
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population, or up to 30% in the Asian area (H ong 
Kong, China, Korea, Taiwan and Singapore)40. In 1992, 
the National Health and Social Life Survey estimated the 
prevalence of FSD at 43%14. Another study involving men 
and women (N=27,500) aged from 40 to 80 years indi-
cated that 39% of sexually active women reported sexual 
activity disorders40. Th e common denominator of most 
studies is a decrease in sexual desire followed by orgasmic 
dysfunction41.
In relation to FSD, many researchers have used the 
Female Sexual Function Index (FSFI). Th e FSFI was 
designed to be an assessment instrument in clinical 
trials addressing the multidimensional nature of fe-
male sexual function14. However, the measures have 
been criticized for their biased results for sexually in-
active samples42. Some authors argued that measuring 
sexual desire with the FSFI might be particularly 
problematic, contending that there is long-standing 
dissatisfaction with outdated models of female sexual 
desire39. Th e relevance of the study based on FSFI is 
focused on acquiring relevant data because in Slovenia, 
information on the prevalence of FSD does not exist.
Materials and Methods
Ethical permission for the cross-national survey 
was obtained from the Slovenian Ethics Committee, 
and investigations were conducted according to the 
Declaration of Helsinki principles. All the participants 
gave a written informed consent before the study. Th e 
cross-national and sectional prevalence study started 
in July 2015 and was concluded in December 2015. 
Four clinical institutions in three diff erent geographi-
cal locations in Slovenia were involved. We intention-
ally selected one clinical institution in the eastern, two 
in the central, and one in the western parts of Slovenia.
We used a validated standardized FSFI question-
naire14. In every clinical institution, we distributed 250 
questionnaires, with the exception of the central part 
of Slovenia, where we distributed 500 questionnaires 
(two in each clinical institution). Th e recruitment pro-
cess was based on the following inclusion conditions: 
(a) adulthood (age ≥18 years); (b) physician’s verbal 
explanation; and (c) personal acceptance and return of 
the questionnaire understood as consent.
Out of the 1000 questionnaires, 623 were returned. 
Th ree hundred and twenty-seven questionnaires were 
fully and 257 partially completed. On statistical analy-
sis, we included all partially completed questionnaires 
(with the exception of some missing demographic data 
and data in relation to endometriosis, all FSFI claims 
were entirely completed). We did not include female 
participants with mental (n=11; 1.8%) and sexual (n=7; 
1.1%) disorders. Th e fi nal sample included 605 female 
participants; the realization of the sample was 60.5%. 
Th e Cronbach alpha coeffi  cient showed an appropriate 
internal consistency for each claim of FSFI question-
naire (desire, arousal, lubrication, orgasm, satisfaction, 
and pain)14 (Table 1).
Table 1. Internal consistency for claims
Claim Questions % (α)
Desire 1,2 1-5 0.856
Arousal 3, 4, 5, 6 0-5 0.950
Lubrication 7, 8, 9,10 0-5 0.961
Orgasm 11, 12, 13 0-5 0.934
Satisfaction 14, 15, 16 0 (or 1)-5 0.897
Pain 17,18,19 0 (or 1)-5 0.977
All terms 0.973
All participants were asked about their demo-
graphic variables including pregnancy and number of 
children, presence of endometriosis and menopause, 
number of sexual partners and sexual orientation, and 
the six major dimensions of female sexual function 
(desire, subjective arousal, lubrication, orgasm, satis-
faction, and pain) in the previous four weeks. For FSFI, 
we used a validated questionnaire with 19 multiple-
choice questions on a 5- or 6-point Likert scale14. Do-
main scores were calculated by summing responses to 
items in each domain, then scaling this total with a 
multiplier that constrains all domains to the same 
range. Linguistic validation of the questionnaire was 
performed based on translation from English to Slo-
venian language and vice versa. Cultural validation was 
not required, based on the constant cultural proportion 
and the lack of cultural diversity in Slovenia.
Statistical analysis
Dat a were analyzed using the SPSS 17.0 statistical 
software. Th e Kolmogorov-Smirnov test and Shapiro-
Wilk test were applied to evaluate whether values had 
a gaussian dis tribution to choose between parametric 
and nonparametric statistical tests. Th e Kolmogorov-
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Smirnov test and Shapiro-Wilk test on six claims of 
FSFI showed a non-normal distribution. Based on this 
fi nding, we used a non-parametric statistical analysis 
by use of Pearson correlation coeffi  cient and χ2-test. 
Statistical signifi cance was set at p<0.05.
Results
Th e sample consisted of the following age groups: 
30-35 (n=122; 20.2%), 24-29 (n=118; 19.5%), 36-41 
(n=90; 14.9%) and 48-53 (n=69; 11.4%). Other groups 
are shown in Table 2. Based on Pearson coeffi  cient, we 
found no positive correlations (see Table 8).
Th e youngest subjects (age 18-23) expressed the 
highest levels of desire and arousal, followed by the 
24-29 age group. Th e 42-47 age group reported the 
highest levels of lubrication and orgasm. Th e claim of 
satisfaction and pain was highest in the 24-29 and 42-
47 age group, respectively (Table 3).
Concerning the level of education, study subjects 
had completed elementary school (n=30; 0.3%), sec-
ondary school (n=275; 45.5%), professional college 
(n=53; 8.8%), college (n=73; 12.1%), university (n=139; 
23%), and master/doctoral degree (n=33; 5.5). Two 
(0.3%) of the respondents did not state their education 
level. Th e claim of arousal and orgasm was best esti-
mated by university educated subjects, followed by 
those with master/doctoral degree and college. Th e 
lowest level was expressed by subjects with elementary 
school (Table 4).
Most of the study participants were not pregnant 
(n=491; 81.2%). Others were pregnant in the 1st (n=34; 
5.6%), 2nd (n=36; 6%) and 3rd trimester (n=37; 6.1%). 
Table 2. Age groups (N=605)











Table 3. Estimation of claims according to age groups
Age group (years)  Desire Arousal Lubrication Orgasm Satisfaction Pain
18-23 M 4.11 4.50 4.99 4.37 4.85 5.12
SD 1.07 1.29 1.43 1.66 1.44 1.61
24-29 M 3.95 4.49 5.12 4.69 5.05 5.26
SD 0.90 1.28 1.42 1.61 1.16 1.45
30-35 M 3.68 4.07 4.69 4.43 4.58 4.67
SD 1.08 1.72 2.01 1.96 1.72 2.12
36-41 M 3.61 4.37 4.86 4.65 4.69 5.12
SD 0.98 1.61 1.76 1.80 1.51 1.82
42-47 M 3.66 4.26 5.13 4.83 4.97 5.34
SD 1.01 1.50 1.46 1.53 1.33 1.55
48-53 M 2.99 3.66 4.46 4.17 4.50 4.97
SD 1.15 1.62 1.81 1.87 1.52 1.78
54-59 M 3.13 3.61 4.06 4.41 4.79 4.90
SD 1.20 1.61 1.77 1.69 1.32 1.67
60-65 M 2.79 2.79 3.29 3.43 3.55 3.88
SD 1.18 1.76 2.13 2.18 1.91 2.42
≥66 M 2.10 1.56 1.74 2.33 4.10 2.13
SD 0.99 1.68 2.34 2.61 1.68 2.55
Total M 3.60 4.11 4.73 4.46 4.72 4.96
SD 1.11 1.60 1.78 1.81 1.50 1.84
p 0.000 0.000 0.000 0.003 0.002 0.000
M = mean; SD = standard deviation; p = level of statistical signifi cance
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Total M 4.11 4.46
SD 1.60 1.81
p 0.001 0.035
M = mean; SD = standard deviation; p = level of statistical signifi -
cance
Table 5. Number of pregnancy and children in the sample
Pregnancy f % Children f %
None 491 81.2 None 225 37.2
1st trimester 34 5.6 One 147 24.3
2nd trimester 36 6.0 Two 198 32.7
3rd trimester 37 6.1 Th ree or more 35 5.8
Delivery (within less than six weeks) 3 0.5
Missing 4 0.7
Total 605 100 605 100
f = frequency
Table 6. Number of sexual partners (N=619)
Sexual partners f %
One partner 535 86.4
Two diff erent partners 11 1.8
Th ree diff erent partners 3 0.5
No sexual intercourse 23 3.8
Missing 45 7.4
Total 605 100
p=0.000; χ2=1714.417; M=1.12; SD=0.86
p = level of signifi cance; M = mean; SD = standard deviation; f = 
frequency
Th ree (0.5%) respondents gave birth less than six 
weeks after the study (p=0.000; χ2=620.045; M=1.36; 
SD=0.89). Four (0.7%) respondents did not provide 
their pregnancy status. Based on the Pearson correla-
tion coeffi  cient, we did not fi nd positive correlations 
with claims (see Table 8). Most of the participants did 
not have children (n=225; 37.2%), 147 (24.3%) had 
one child, 198 (32.7%) had two children, and 35 (5.8%) 
had three or more children (p=0.000; χ2=140.897; 
M=2.08; SD=0.96) (Table 5). Based on the Pearson 
correlation coeffi  cient, we did not fi nd positive correla-
tions with claims (see Table 8).
Menopause was not detected in 503 (83.1%) par-
ticipants. Th e sample included eight (1.3%) meno-
pausal women on hormone replacement therapy and 
85 (14%) menopausal women without hormone re-
placement therapy (p=0.000; χ2=1115.613; M=1.16; 
SD=0.44).
Most of the participants were free from endome-
triosis (n=576; 95.2%). Fourteen (2.3%) women were 
diagnosed with endometriosis and had undergone one 
surgical therapy (n=14; 2.3%), while another four 
(0.7%) had undergone additional surgical therapies. 
Four (0.7%) women had not been involved in any sur-
gical procedure. Seven (1.2%) participants did not an-
swer this part of the questionnaire (p=0.000; χ2=2192, 
289; M=1.04; SD=0.34). Based on the Pearson corre-
lation coeffi  cient, we did not fi nd positive correlations 
between menopause, endometriosis, and claims from 
the questionnaire (see Table 8).
Most of the respondents had sexual intercourse 
with one partner (n=535; 86.4%). Th e rest of the re-
spondents were involved in sexual intercourse with 
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Table 7. Sexual relationship (N=604)






p=0.000; x2=1714.417; M=0.99; SD=0.25
p = level of signifi cance; M = mean; SD = standard deviation; f = 
frequency



























































E Frequency 0.07 -0.006 -0.236** -0.153** 0.012 -0.032 -0.129**







L Frequency 0.215** -0.015 -0.176** -0.088* -0.002 -0.06 -0.271**
Level 0.167** -0.038 -0.148** -0.065 0.015 -0.016 -0.328**
Confi dence 0.157** 0 -0.154** -0.093* 0.005 -0.028 -0.340**









N Frequency 0.143** -0.038 -0.167** -0.093* -0.006 -0.028 -0.315**
Diffi  culty 0.083* -0.032 -0.112** -0.018 0.005 -0.005 -0.361**
Frequency of maintaining 0.175** -0.018 -0.148** -0.057 -0.008 -0.024 -0.319**







** -0.006 -0.097* 0.032 0.041 -0.022 -0.232**
Diffi  culty 0.124** -0.018 -0.056 0.023 0.009 0.022 -0.328**










N With amount of closeness 0.117** 0.001 -0.068 -0.058 0.01 -0.026 -0.407**
With sexual relationship 0.084* 0 -0.068 -0.032 0.019 -0.014 -0.380**




With frequency during penetration 0.093* -0.061 -0.089* 0.009 -0.017 -0.004 -0.394**
Frequency following penetration 0.07 -0.043 -0.101* -0.009 -0.01 -0.017 -0.405**
Intensity during or following penetration 0.090* -0.035 -0.107** -0.016 0.002 -0.004 -0.398**
*p<0.005; **p<0.001
two (n=11; 1.8%) and three (n=3; 0.5%) diff erent part-
ners. Twenty-three (3.8%) respondents reported no 
sexual activity (Table 6). Based on the Pearson coeffi  -
cient, we did not fi nd positive correlations with these 
claims (see Table 8).
Most of the sexual relationships were heterosexual 
(n=584; 96.5%). A small proportion were bisexual (n=4; 
0.7%) and homosexual (n=2; 0.3%) (Table 7). Based on 
the Pearson correlation coeffi  cient, we did not fi nd pos-
itive correlations with these claims (Table 8).
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Th e respondents used diff erent methods of contra-
ception. It should be noted that the majority (n=304; 
50.2%) did not use any of the contraception methods 
listed in the questionnaire. We should note that 110 
(18.2%) respondents were pregnant or had given birth. 
Some (n=19; 3.1%) used interruption of sexual inter-
course as a method of contraception. From the list of 
contraception methods, the respondents most com-
monly used condoms (n=112; 18.5%) and contracep-
tive pills (n=80; 13.2%).
Based on the Pearson correlation coeffi  cient, we 
detected strong linear associations between desire and 
arousal (r=0.856), arousal and lubrication (r=0.879), 
lubrication and arousal (r=0.879), orgasm and arousal 
(r=0.862), satisfaction and orgasm (r=0.782), and pain 
and lubrication (r=0.782) (Table 9).
Th e estimation of FSD was based on the Receiver 
Operating Characteristic (ROC) and Classifi cation 
and Regression Trees (CART) analysis43. Th e preva-
lence was estimated based on the model that contains 
one variable, which represents the total score of points 
in all domains. If the total number of points is equal to 
or greater than 26.55, sexual dysfunction is not present 
in 88.1% of cases. However, if the result is lower, sexu-
al dysfunction is present in at least one of the domains 
in 77.7% of cases. Accordingly, the risk of sexual dys-
function is present in each subject with a total score of 
26.55 or lower.
To calculate the prevalence, we initially divided the 
sample into two groups: one group including women 
with a total score of FSFI higher than 26.55 and the 
other one with a lower score. In each group, we calcu-
lated the sum of all female subjects. In the fi rst group, 
we recorded a higher overall result in 375 (69%) and in 
the second group in 169 (31%) subjects. Th e results 
obtained yielded the prevalence of FSD in Slovenia 
of 31%.
Discussion
Based on our research, the prevalence of sexual dys-
function in Slovenia is 31%. Several exogenous and 
endogenous factors infl uence the subjective meaning 
of sexuality. Among endogenous factors, the organic 
substratum, i.e. pathology and pathophysiology of tis-
sues, should be mentioned. Th e psychological factors 
also play a signifi cant role in the individual perception 
of the appropriate or inappropriate sexual stimuli. Bas-
son et al.15 argued that depression interfered with fe-
male sexual response, with a negative association 
among desire, arousal, satisfaction, orgasm, and pain. 
Future studies should not just involve individual per-
ceptions and (mis)understandings, but as Meils et al.44 
argued, the impact of the couple’s relationship quality 
in sexual function should be investigated.
With the growth and development of the female 
body, changes occur in the perception, understanding 
and needs of sexual stimuli. Th e youngest females (18-
23 and 24-29 age groups) reported higher levels of the 
physiological and psychological stimuli linked with 
desire, arousal and satisfaction. At later ages (42-47 
age group), changes also occur, focused on lubrication, 
orgasm, and pain. In addition to age, the level of edu-
cation represents a strong infl uential factor. Sexual 
stimuli are oriented on arousal and orgasm.
In addition to growth, development, chronologic 
age and education, sexual stimuli are infl uenced by 
several other factors, such as acquisition of knowledge, 
adoption of values, and spiritual growth45-47.
Based on our study, we conclude that arousal is 
linked to desire, orgasm, and lubrication. Lubrication 
aff ects desire and pain, and orgasm plays a vital role in 
satisfaction (Fig. 1). Th eoretically, from the physiologi-
cal/psychological point of view, we could conclude that 
the sexual cycle fi rst involves desire, arousal, lubrica-
Table 9. Pearson correlation coeffi  cient among claims
 Desire Arousal Lubrication Orgasm Satisfaction Pain
Desire - 0.585* 0.470* 0.434* 0.455* 0.348*
Arousal 0.585* - 0.879* 0.856* 0.770* 0.776*
Lubrication 0.470* 0.879* - 0.839* 0.749* 0.856*
Orgasm 0.434* 0.856* 0.849* - 0.782* 0.757*
Satisfaction 0.455* 0.779* 0.749* 0.782* - 0.717*
Pain 0.348* 0.765* 0.856* 0.757* 0.717* -
*Correlation signifi cant at the 0.01 level (2-tailed)
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tion, orgasm, and fi nally satisfaction. It is interesting 
that the claim of orgasm is not linked to desire and 
lubrication. Th eoretically, orgasm cannot occur with-
out arousal and lubrication, and previously without 
desire.
More studies will be required to respond to the is-
sue of whether orgasm can occur during the rape of 
female victims48. 
Limitations
Th e current research had some limitations. We 
should note that sexual dysfunction itself has a diverse 
etiology, and we could not be entirely objective. Other 
limitations arose from the methodology: 1) we did not 
use face-to-face interviews because they could embar-
rass people when talking about privacy issues, al-
though, according to some authors, data compiled 
through methods such as online surveys are fraught 
with bias and misinformation; and 2) the unequal dis-
tribution of the questionnaires might aff ect the demo-
graphic correlations made in the study.
Conclusions
Th is study was one of the fi rst attempts to assess 
the prevalence of sexual dysfunction among female 
adults in Slovenia. We took a well-validated, common-
ly used questionnaire for fast and accurate screening of 
FSD. Th e study signifi cantly contributed to the under-
standing of female sexual function and the infl uence of 
age and level of education on the perception, under-
standing and needs of sexual stimuli, and on the preva-
lence of FSD in Slovenia.
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Sažetak
SEKSUALNA FUNKCIJA I DISFUNKCIJA ŽENE: NACIONALNO ISTRAŽIVANJE UČESTALOSTI 
U SLOVENIJI
A. Starc, T. Jukić, B. Poljšak i R. Dahmane
Cilj ovoga istraživanja bio je procijeniti učestalost seksualne disfunkcije kod žena u Sloveniji. Ispitivala se učestalost dis-
funkcije s usporedbom demografskih skupina i moguće korelacije. Podaci su prikupljani pomoću potvrđenog standardizira-
nog Indeksa seksualne funkcije žene (N=605). Većina sudionica u istraživanju imala je seksualni odnos s jednim partnerom 
(n=523) i većina seksualnih odnosa bila je heteroseksualna (n=584). Najveće zahtjeve za uzbuđivanje imale su osobe s fakul-
tetskim obrazovanjem, a nakon njih one s magisterijem i doktoratom te osobe s višom školom. Najnižu razinu izrazile su 
osobe s osnovnom školom. Najmlađa dobna skupina (18-23 godine) izrazila je najviše razine želje i uzbuđenja, a nakon nje 
dobna skupina od 24-29 godina. Dobna skupina od 42-47 godina izrazila je najviše razine lubrikacije i orgazma. Zahtjev 
zadovoljavanja bio je najviši u skupini od 24-29 godina, dok je bolnost bila najviša u skupini od 42-47 godina. Utvrđena je 
snažna korelacija između zahtjeva želje i uzbuđivanja (r=0,585), uzbuđivanja i lubrikacije (r=0,879), lubrikacije i boli (r=0,856), 
orgazma i lubrikacije (r=0,856), zadovoljenja i orgazma (r=0,782) te boli i uzbuđivanja (r=0,776). Utvrđena je učestalost 
seksualne disfunkcije kod žena u Sloveniji od 31%.
Ključne riječi: Orgazam; Slovenija; Koitus; Uzbuđenje; Lubrikacija; Bol; Seksualne disfunkcije, psihološke; Seksualne disfunk-
cije, fi ziološke
